Tralokinumab‐induced injection‐site reactions-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tralokinumab‐induced injection‐site reactions

Published:2024-08-11 Issue: Volume: Page:
ISSN:0105-1873
Container-title:Contact Dermatitis
language:en
Short-container-title:Contact Dermatitis

Author:

De Greef Axel¹²^ORCID,Baeck Marie¹²

Affiliation:

1. Department of Dermatology Cliniques universitaires Saint‐Luc, Université catholique de Louvain (UCLouvain) Brussels Belgium

2. Institute of Experimental and Clinical Research (IREC), Pneumology, ENT and Dermatology Pole (LUNS), Université catholique de Louvain (UCLouvain) Brussels Belgium

Funder

Fonds De La Recherche Scientifique - FNRS

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cod.14671

Reference5 articles.

1. Efficacy and Safety of Tralokinumab in Adolescents With Moderate to Severe Atopic Dermatitis

2. Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*

3. Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study

4. Tralokinumab improves clinical scores in adolescents with severe atopic dermatitis: A real‐life multicentric observational study

5. Injection site reactions after dupilumab or tralokinumab for atopic dermatitis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP